2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy And Planning 2018, 33: 528-538. PMID: 29529282, PMCID: PMC5894072, DOI: 10.1093/heapol/czy018.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisDeveloping CountriesHealth PlanningHepatitis BHepatitis CHumansPolicy MakingResource AllocationSouth AfricaTransitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research
Resch S, Hecht R. Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research. Journal Of Global Health 2018, 8: 010301. PMID: 29391944, PMCID: PMC5782833, DOI: 10.7189/jogh.08.010301.Peer-Reviewed Original Research
2015
Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries
Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. The Lancet Global Health 2015, 3: e52-e61. PMID: 25539970, DOI: 10.1016/s2214-109x(14)70342-0.Peer-Reviewed Original ResearchConceptsDomestic spendingRecipient country governmentsLow-income countriesCapacity of countriesEconomic growthDomestic expenditureHealth spendingCountry governmentsFinancing requirementsFunding gapFinancial agreementsFunding requirementsSpendingDonor fundsMiddle-income countriesIncome countriesDomestic sourcesNational governmentsDonor supportCountriesDonor contributionsNational prioritisationAvailable fundingGovernmentFunding partners
2014
Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
Saxenian H, Hecht R, Kaddar M, Schmitt S, Ryckman T, Cornejo S. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries. Health Policy And Planning 2014, 30: 197-205. PMID: 24510369, PMCID: PMC4325534, DOI: 10.1093/heapol/czu003.Peer-Reviewed Original Research
2011
Transparent pricing of vaccines would help poor as well as rich countries
Hecht R, Kaddar M, Schmitt S. Transparent pricing of vaccines would help poor as well as rich countries. The BMJ 2011, 343: d7414. PMID: 22113835, DOI: 10.1136/bmj.d7414.Peer-Reviewed Original ResearchEconomic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R. Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLOS ONE 2011, 6: e25310. PMID: 21998648, PMCID: PMC3187775, DOI: 10.1371/journal.pone.0025310.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAnti-HIV AgentsChildCost-Benefit AnalysisDeveloping CountriesEmploymentHumansIncomeInvestmentsTime FactorsConceptsMiddle-income countriesAIDS treatmentProgram costsIncome countriesLarge health gainsAntiretroviral therapyHIV infectionOpportunistic infectionsGlobal FundLife careMedical treatmentAIDS diseaseTreatment programHealth gainsCurrent cohortTotal program costsTreatmentPatientsCohortInfectionCareEnd 2011Same periodEconomic benefitsLabor productivity effectsAn Analysis Of How The GAVI Alliance And Low- And Middle-Income Countries Can Share Costs Of New Vaccines
Saxenian H, Cornejo S, Thorien K, Hecht R, Schwalbe N. An Analysis Of How The GAVI Alliance And Low- And Middle-Income Countries Can Share Costs Of New Vaccines. Health Affairs 2011, 30: 1122-1133. PMID: 21653966, DOI: 10.1377/hlthaff.2011.0332.Peer-Reviewed Original Research
2010
Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31
Hecht R, Stover J, Bollinger L, Muhib F, Case K, de Ferranti D. Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31. The Lancet 2010, 376: 1254-1260. PMID: 20934597, DOI: 10.1016/s0140-6736(10)61255-x.Peer-Reviewed Original ResearchConceptsMiddle-income countriesLong-term funding needsLow-income countriesHIV/AIDS fundingOutside fundsPolicy choicesFunding needsStrategic investmentsEfficiency gainsEfficient mobilisationRepresentative countriesAIDS fundingCountriesFundsRange of scenariosShort termGlobal HIV/AIDS pandemicHIV/AIDS programsCostHIV/AIDS responseManagement of resourcesSubstantial variationFinancingInvestmentHIV/AIDS
2009
Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic
Hecht R, Bollinger L, Stover J, McGreevey W, Muhib F, Madavo CE, de Ferranti D. Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic. Health Affairs 2009, 28: 1591-1605. PMID: 19887401, DOI: 10.1377/hlthaff.28.6.1591.Peer-Reviewed Original ResearchImproving Health R&D Financing For Developing Countries: A Menu Of Innovative Policy Options
Hecht R, Wilson P, Palriwala A. Improving Health R&D Financing For Developing Countries: A Menu Of Innovative Policy Options. Health Affairs 2009, 28: 974-985. PMID: 19597195, DOI: 10.1377/hlthaff.28.4.974.Peer-Reviewed Original Research
2007
The Impact Of An AIDS Vaccine In Developing Countries: A New Model And Initial Results
Stover J, Bollinger L, Hecht R, Williams C, Roca E. The Impact Of An AIDS Vaccine In Developing Countries: A New Model And Initial Results. Health Affairs 2007, 26: 1147-1158. PMID: 17630459, DOI: 10.1377/hlthaff.26.4.1147.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesDeveloping CountriesDisease SusceptibilityDrug EvaluationFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedModels, StatisticalPatient SelectionProbabilityResearch Support as TopicRisk AssessmentRisk FactorsRisk-TakingSexual BehaviorSubstance Abuse, Intravenous